Company Filing History:
Years Active: 2011
Title: Innovator Spotlight: Ji Myun Jang
Introduction: Ji Myun Jang is an accomplished inventor based in Yongin-si, South Korea. With a focus on medical advancements, he has contributed significantly to the field of pharmaceuticals, particularly in the treatment of diabetes and obesity.
Latest Patents: Ji Myun Jang holds a patent for a DPP-IV inhibitor that includes a beta-amino group. This innovation covers a novel heterocyclic compound, the method for preparing it, and a pharmaceutical composition aimed at preventing and treating DPP-IV-related diseases such as diabetes or obesity. The compound showcases remarkable DPP-IV inhibitory activity and bioavailability, making it a promising candidate for medical therapies.
Career Highlights: Ji Myun Jang is currently employed at Dong-A Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His career is marked by a strong dedication to research and development, focusing on formulations that address critical health issues.
Collaborations: Throughout his career, Ji Myun Jang has collaborated with talented individuals, including Heung Jae Kim and Woo Young Kwak. Their combined expertise contributes to the innovative environment at Dong-A Pharmaceutical Co., Ltd., fostering advancements in pharmaceutical development.
Conclusion: Ji Myun Jang is a noteworthy inventor whose work significantly impacts the treatment of chronic conditions like diabetes and obesity. His patent on a DPP-IV inhibitor demonstrates his commitment to improving healthcare through innovation. As he continues to collaborate with industry colleagues, the future looks promising for further advancements in pharmaceutical research.